$2.99
+0.1
(+3.46%)▲
Live
6.02%
Downside
Day's Volatility :18.31%
Upside
13.08%
92.94%
Downside
52 Weeks Volatility :92.94%
Upside
0.0%
Period | LANDOS BIOPHARMA INC | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 680.87% | 0.3% | -6.7% |
6 Months | 1244.19% | -8.3% | -6.2% |
1 Year | 297.96% | -4.8% | -6.3% |
3 Years | -75.92% | 23.8% | 26.9% |
Market Capitalization | 90.1M |
Book Value | $1.51 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -6.13 |
Wall Street Target Price | 5.5 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -31.14% |
Return On Equity TTM | -55.8% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 18.0M |
EBITDA | -31.7M |
Diluted Eps TTM | -6.13 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -4.47 |
EPS Estimate Next Year | -3.6 |
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Next Quarter | -0.1 |
What analysts predicted
Upside of 83.95%
Sell
Neutral
Buy
LANDOS BIOPHARMA INC is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() LANDOS BIOPHARMA INC | 896.55% | 1244.19% | 297.96% | -75.92% | -75.92% |
![]() Moderna, Inc. | -5.37% | -28.24% | -13.14% | 103.02% | 578.71% |
![]() Regeneron Pharmaceuticals, Inc. | -10.12% | -3.55% | 9.07% | 20.95% | 140.97% |
![]() Seagen, Inc. | -2.85% | 59.4% | 42.61% | 21.68% | 240.77% |
![]() Vertex Pharmaceuticals Incorporated | -4.35% | 4.3% | 22.83% | 15.12% | 110.67% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() LANDOS BIOPHARMA INC | NA | NA | NA | -4.47 | -0.56 | -0.31 | 0.0 | 1.51 |
![]() Moderna, Inc. | 11.22 | 11.22 | 0.0 | -1.83 | 0.27 | 0.12 | 0.0 | 49.12 |
![]() Regeneron Pharmaceuticals, Inc. | 19.72 | 19.72 | 9.01 | 41.59 | 0.19 | 0.1 | 0.0 | 219.38 |
![]() Seagen, Inc. | NA | NA | 18.53 | -2.88 | -0.23 | -0.12 | 0.0 | 14.54 |
![]() Vertex Pharmaceuticals Incorporated | 26.53 | 26.53 | 0.41 | 13.64 | 0.26 | 0.17 | 0.0 | 56.05 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() LANDOS BIOPHARMA INC | Sell | $90.1M | -75.92% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $48.1B | 578.71% | 11.22 | 31.77% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $79.5B | 140.97% | 19.72 | 33.81% |
![]() Seagen, Inc. | Hold | $36.3B | 240.77% | NA | -31.55% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $85.0B | 110.67% | 26.53 | 35.4% |
Perceptive Advisors LLC
Macquarie Group Ltd
Geode Capital Management, LLC
Renaissance Technologies Corp
Warberg Asset Management LLC
HRT FINANCIAL LLC
LANDOS BIOPHARMA INC’s price-to-earnings ratio stands at None
Read MoreOrganization | LANDOS BIOPHARMA INC |
Employees | 22 |
CEO | Mr. Timothy M. Mayleben M.B.A. |
Industry | Healthcare |
First Majestic Silver Corp
$5.75
+0.0%
ONYX ACQUISITION CO. I
$10.49
-4.64%
Diversified Healthcare Trust
$1.17
+2.63%
ALTC ACQUISITION CORP-CL A
$10.70
+0.47%
iShares Morningstar Value ETF
$63.25
-0.25%
Nationwide Nasdaq-100 Risk-Managed Income ETF
$20.52
+0.2%
ENFUSION INC
$7.81
-0.89%
WisdomTree Trust - WisdomTree International Quality Dividend Growth Fund
$33.66
-0.59%
GIGACLOUD TECHNOLOGY INC
$6.63
+2.79%